Sen. Collins, Colleagues Secure Omnibus Provision to Close E-Cigarette Loophole, Regulate Synthetic Nicotine
March 15, 2022
March 15, 2022
WASHINGTON, March 15 -- Sen. Susan M. Collins, R-Maine, issued the following news release:
Following a successful bipartisan effort co-led by U.S. Senator Susan Collins (R-ME), a member of the Senate Health Committee, the Fiscal Year 2022 omnibus appropriations package included a provision that will clarify the Food and Drug Administration's (FDA) ability to regulate products containing synthetic nicotine as tobacco products. The omnibus passed the House and the Senate and now . . .
Following a successful bipartisan effort co-led by U.S. Senator Susan Collins (R-ME), a member of the Senate Health Committee, the Fiscal Year 2022 omnibus appropriations package included a provision that will clarify the Food and Drug Administration's (FDA) ability to regulate products containing synthetic nicotine as tobacco products. The omnibus passed the House and the Senate and now . . .